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Quantification o f Feline Immunodeficiency Virus (FIVpco) in peripheral blood 
mononuclear cells, lymph nodes and plasma of naturally infected cougars
Chair: Stephen Lodmell
Infection o f domestic cats widi Feline Immunodeficiency Virus (FIV) results in a fatal 
immunodeficiency disease, similar to human immunodeficiency virus type-1 (HIV-1) in 
humans. Elevated plasma viral loads in domestic cats are correlated to decreased survival 
time and disease progression. FIV is also maintained as an apathogenic infection in other 
members o f the family Felidae including cougars. Puma concolor (FIVpco). It is not 
known whether the lack of disease in cougars is a result o f diminished viral replication. A 
real-time PCR assay was developed to quantify both FIVpco pro viral and plasma viral 
loads in naturally infected cougars. Pro viral loads quantified from peripheral blood 
mononuclear cells (PBMC) ranged from 2.90x10^ to 6.72x10"^ copies per 10^ cells. 
Plasma viral loads ranged from 2.30x10^ to 2.81x10^ RNA copies per ml. These data 
indicate that FIVpco viral loads are comparable to viral loads observed in endemic primate 
lentivirus infections. Thus the lack o f disease in cougars is not due to low levels o f viral 
replication. Moreover, significant differences observed among cougar PBMC proviral 
loads correlated to viral lineage and cougar age (P = 0.014), which suggests that sepairate 
life strategies exist within FIVpco lineages. This is the first study to demonstrate that an 
interaction o f lentiviral lineage and host age significantly affects proviral loads.
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Chapter 1 
Introduction
Introduction to lentiviral infections and disease
Lenti viruses are RNA viruses associated with the family Retroviridae. These 
viruses replicate their genomes through a reverse transcriptase enzyme and are frequently 
characterized by an extended incubation period prior to any evident signs of disease. For 
example, human immunodeficiency virus type-1 (HIV-1) infection in humans begins 
with an acute infection and over a period o f years, progresses to immunodeficiency and 
ultimately death. While much attention has been paid to HIV-1 because o f its enormous 
public health threat (Armstrong et al., 2005), lentiviruses infect a number o f  other 
animals such as sheep (visna virus), horses (equine infectious anemia virus), non-human 
primates (simian immunodeficiency virus (SIV)) and felines (feline immunodeficiency 
virus (FIV)) (Ligne, 1843, Lowenstine et al., 1986, Sigurdsson et al., 1952). Although 
many lentivirus infections are associated with disease, such as HIV-1 in humans and FIV 
in domestic cats, some lentivirus infections are endemic within wild populations and do 
not result in disease. For example, endemic lentivirus infections in African green 
monkeys (SIVagm), sooty mangabeys (SIVsm) and cougars (FIVpco) results in no 
observable disease despite elevated viral loads (Holzammer et al., 2001, Olmsted et al., 
1992, Rey-Cuille et al., 1998). Therefore, all lentivirus infections are not associated with 
pathogenic diseases.
Genomic organization o f FIV
Feline immunodeficiency virus (FIV ) is a lentivirus that infects members o f the 
family Felidae worldwide. Although all FIV strains detected in wild and domestic cats 
form a monophyletic cluster in a phylogeny o f lentiviruses, each feline species is infected 
with a distinct virus and infection results in disparate outcomes (Burkhard & Dean, 2003). 
FIV is maintained as an apathogenic infection in some members o f the cat family such as 
lions {Panthera led) and cougars {Puma concolor) (FIVpco) (Brown et al., 1994,
Carpenter & O'Brien, 1995, Olmsted et al., 1992). However, FIV infection in domestic 
cats results in a disease similar to HIV-1 in humans (Bendinelli et al., 1995, Pedersen et 
al., 1987).
The genome of FIV encodes three genes that are common to all retroviruses; gag, 
po l and env. Gag and env encode structural proteins that are necessary for virion 
assembly while po l encodes the enzymes needed for viral replication (Burkhard & Dean, 
2003, Inoshima et al., 1998). Since FIV is a lentivirus, it also contains additional 
accessory genes that encode nonstructural proteins that alter viral gene expression and 
pathogenesis. One o f these accessory genes, rev, is conserved across all lentiviruses and 
provides an essential mechanism by which partially and unspliced viral RNAs are 
exported from the nucleus (Miller et al., 2000). A transactivating gene is also encoded by 
all lentiviruses and plays an important role in viral transcription. The transactivating 
protein in FIV, Orf2, also facilitates transactivation but through a unique mechanism 
compared to transactivating proteins from other lentiviruses (Chatterji et al., 2002). Kz/'is 
also encoded by all lentiviruses except equine anemia virus and is necessary in HIV-1 
infections to suppress a host-derived antiviral factor, APOBEC3G (Rose et al., 2004).
FIV is genetically distinct from primate lentiviruses because it encodes a dUTPase gene
(Miller et al., 2000). dUTPase hydrolyzes dUTP into dUMP to maintain a low 
concentration o f dUTP in the cell in order to reduce the opportunity o f uracil 
misincorporation during reverse transcription. Finally, FIV does not encode accessory 
proteins such as vpr^ vpu or n e f  as primate lentiviruses do.
Retroviral Life Cycle
Although FIV is phylogenetically distinct from other lentiviruses, the viral life 
cycles o f all lentiviruses are similar and can be divided into six distinct steps that include 
entry, uncoating, integration, transcription, assembly and budding (Fig. 1.1). FIV utilizes 
CD 134 as a primary receptor as well as the chemokine coreceptor, CXCR4 for 
attachment and entry (de Parseval et al., 2004a, de Parseval et al., 2004b, Shimojima et 
al., 2004). After attachment and membrane fusion the viral core, which includes the full- 
length genomic RNA and the viral reverse transcriptase (RT), is deposited into the 
cytoplasm. The viral genomic RNA is reverse transcribed by RT to form a full-length 
double stranded DNA copy. The double-stranded DNA then forms a preintegration 
complex with viral integrase (IN) and translocates to the nucleus. Integration o f the viral 
DNA is catalyzed by IN and results in the random insertion of the viral DNA into the 
host genome. The integrated viral DNA form is called the pro virus. After integration, 
transcription o f the pro virus by the host cell RNA polymerase II produces both full length 
genomic RNA as well as singly and fully spliced viral transcripts. These transcripts are 
subsequently translated into viral proteins such as Gag and Gag-Pol precursors, which are 
assembled into immature viral particles along with the full length genomic RNA. The 
assembled immature virions then bud from the host cell membrane. Mature virions are
produced after the viral protease (PR) cleaves the Gag and Gag-Pol precursors to form 
infectious viruses. Hence, lentiviruses exist as an integrated DNA provirus within an 
infected cell and as a cell free RNA virus circulating in the blood.
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Figure 1.1 : A schematic o f the retroviral life cycle. Lentiviruses exist in both an RNA and 
DNA form during infection. Lentiviruses are present as infectious cell free virions, which 
contain the full length viral genomic RNA (indicated in red). After attachment and entry, 
the genomic RNA is reverse transcribed to double-stranded DNA (indicated in green) and 
integrated into the host cell genome (indicated in black), which is called the provirus.
Importance o f  viral loads on disease progression
Viral expression levels provide important information on the state o f pathogenic 
lentivirus infections. In both HIV-1 and FIV infections, the acute stages o f infection are 
associated with high plasma viral loads (Diehl et al., 1995, Piatak et al., 1993a, Piatak et 
al., 1993b). As the infection persists, viral RNA levels decrease and usually remain 
detectable throughout the infection. Viral RNA levels increase again in the terminal stage 
o f the infection (Diehl et al., 1995, Gupta et al., 1993). Although viral expression levels 
increase during the beginning and end o f pathogenic lentivirus infections, the amount of
cell free virus during the asymptomatic stage o f the infection is the most robust 
prognostic indicator for disease progression and has been shown to correlate to survival 
times in FIV and HIV-1 (Diehl et al., 1996, Goto et al., 2002, Mellors et al., 1996).
Plasma viral loads have been shown to correlate to disease stage in both 
experimental and natural FIV infections in domestic cats. Domestic cats experimentally 
infected with FIV that progress rapidly to disease maintain plasma viral loads 1 to 2 logs 
higher than long-term survivors (Diehl et al., 1996). Moreover, the total amount o f anti- 
FIV antibodies is not different between rapid disease progressors and long-term survivors 
indicating that FIV replication plays an important part in FIV disease progression. The 
premise that plasma viral loads are correlated to disease in FIV infections is also 
supported by observations from naturally infected domestic cats. High plasma viral loads 
(> 10^ RNA copies per ml) in naturally infected domestic cats correlate to progression to 
feline AIDS as well as decreased survival times (Goto et al., 2002). Therefore, the 
amount o f virus circulating in the blood o f infected domestic cats provides a strong 
clinical marker for disease outcome and survival time during FIV infections.
Since elevated plasma viral loads are also correlated to disease progression in 
patients infected with HIV-1 (Mellors et al., 1996), patients currently receive highly 
active retroviral therapy (HAART), which enables them to remain free from clinical 
symptoms. HAART includes a combination o f nucleoside and nonnucleoside inhibitors 
o f  the reverse transcriptase and protease enzymes that substantially inhibit the level o f 
viral replication and decrease plasma viral loads to undetectable levels (Kulkosky & 
Pomerantz, 2002). Once plasma viral loads decrease to undetectable levels in patients 
(<50 copies per ml o f  blood), proviral loads become an important measure o f efficacy of
antiretroviral therapy. The proviral reservoir is the major obstacle in the complete 
eradication o f the virus. HAART therapy has been shown to also decrease HIV-1 proviral 
loads, however the rate at which HIV-1 proviral loads decrease are much lower than that 
o f plasma viral loads (Dickover et al., 1992). Therefore, after prolonged HAART therapy, 
proviral loads provide a second clinical marker by which to compare the efficacies o f 
different antiretroviral therapies (Desire et al., 2001, Dickover et al., 1992).
Viral loads in endemic apathogenic SIV infections
In contrast to pathogenic lentivirus infections in domestic cats and humans, 
primates infected with SIV maintain substantial viral loads but do not progress to disease. 
The amount o f cell associated and cell free virus in infected African green monkeys 
(AGM) and sooty mangabeys (SM) indicates that these infected primates maintain viral 
loads equivalent or higher than viral loads in pathogenic lentivirus infections in domestic 
cats or humans despite remaining free from disease. For example, proviral loads 
quantified in three naturally infected sooty mangabey ranged from 2450 to 6020 DNA 
copies per 10^ PBMCs, with a mean o f 4.6x10^. Plasma viral loads quantified from these 
SM ranged from 4.7x10^ to 1.2x10^ RNA copies per ml (Rey-Cuille et al., 1998). In 
African green monkeys proviral loads were lower than in SM and ranged from 33 to 333 
DNA copies per 10^ PBMCs and 333 to 3333 DNA copies per 10^ LN cells. However, 
plasma viral loads quantified from AGM in a separate study were similar in magnitude to 
SM (range 3.5x10^ to >9.5 xlO^ copies/ml) (Broussard et al., 2001). One study quantified 
plasma viral loads in six AGM ranging from less than 10  ̂RNA copies per ml to 8x10^ 
(Goldstein et al., 2000). In a much larger study, viral loads in AGM ranged from 8.3x10^
to 1.1x10^, with a mean of 1.7x10^ RNA copies per ml (Holzammer et al., 2001). These 
data clearly indicate that naturally infected SM and AGM maintain a productive lentiviral 
infection despite remaining free from disease. Therefore, the amount of virus in an 
infected individual or animal is not always predictive o f disease.
Quantification o f viral loads
Since viral loads are frequently an informative measure o f disease progression, 
several methods have been designed to quantify the amount o f virus in an infected animal 
or patient. Competitive PCR is one method used to measure viral loads (Clementi et al., 
1994, Orlando et al., 1998). In competitive PCR both the target and a truncated 
competitor are amplified simultaneously with the identical forward and reverse primer set. 
To insure that quantification through competitive PCR is accurate, the amplification 
efficiencies o f both the target and competitor must be equal. When both templates 
amplify uniformly, the ratio of template and competitor will remain constant throughout 
the PCR. Therefore, to quantify the initial amount o f target, an equal ratio o f target to 
competitor must be identified through amplification and subsequent densitometry 
analysis. The initial amount o f target is then calculated by determining the starting 
quantity of competitor used in that particular reaction.
Competitive PCR is labor intensive and necessitates much post-PCR analysis. 
Even before quantification begins, a DNA or RNA competitor must be created for every 
target o f interest and that competitor must amplify with equal efficiency. Several 
dilutions must be tested to achieve a suitable ratio. Furthermore, the post-PCR 
quantification must be thorough and accurate to provide a correct estimation o f the initial
target amount. After all these controls are completed, the initial amount of target can only 
be calculated to within a ten-fold difference o f the competitor.
Competitive PCR has been previously used to measure feline proviral loads from 
several different tissues in domestic cats (Pistello et al., 1994). The number of FIV copies 
per microgram o f genomic DNA was quantified by utilizing a fixed amount o f cellular 
DNA and a known amount o f competitor DNA with a 21 base pair deletion,. Interestingly, 
a dynamic range o f proviral loads were quantified, ranging from 4300 copies in CNS 
tissue to as low as 10 copies per 10^ cells in ovary tissue. However, since the target 
amplicon was larger the results may be skewed due to an increased amount o f ethidium 
bromide being incorporated into the target amplicon compared to the competitor, which 
would produce inaccurate results (Pistello et al., 1994). A second group worked to 
eliminate this quantification problem by utilizing a fluorescent labeled second round PCR 
primer to create a more specifically labeled PCR product (Cammarota et al., 1996). 
However, a separate enzyme digestion was necessary after amplification, which created 
another possible vairiable in the quantification. Competitive PCR is labor intensive and 
does not always lead to repeatable, accurate results. Consequently, a more sensitive and 
accurate method o f quantification has been developed.
Real-time PCR is a quantitative fluorescent-based PCR method that monitors the 
level o f  fluorescence during every cycle o f a PCR reaction (i.e. in real-time) (Niesters, 
2002). The fluorescent signal is proportionate to the amount of PCR product in the 
reaction and increases every cycle. Real-time PCR accurately quantifies the initial 
amount o f target template by comparing the level o f fluorescence o f an unknown sample 
to the fluorescence o f a known copy number standard. Quantification through real-time
S
PCR is quicker than competitive PCR methods because real-time PCR eliminates any 
post-PCR processing steps. More importantly real-time PCR is able to detect a number of 
target templates over a broad dynamic range thereby making quantification more accurate 
(Niesters, 2001).
A variety o f different chemistries are currently available for real-time PCR assays. 
For example, Taqman chemistry utilizes a fluorogenic probe during PCR amplification 
that specifically hybridizes to the teirget sequence. Taqman probes are oligonucleotides 
slightly longer than the primers that contain a fluorescent reporter on the 5’ end along 
with a quencher at the 3 ’ end. When the probe is not bound to the target sequence and 
then irradiated during amplification, the fluorescent dye excites and its energy is 
transferred to the quencher producing no fluorescent signal. However, when the probe 
hybridizes to the target sequence, the reporter is cleaved by the 5’ exonuclease activity of 
the Taq polymerase during the extension step o f the PCR reaction. Cleavage and 
subsequent irradiation results in an increase in fluorescence. Since the probe only 
hybridizes with the target sequence, it is specific. Moreover, Taqman chemistry is able to 
detect down to a single copy o f the target sequence in a given reaction. Therefore, 
because o f its specificity and sensitivity, Taqman chemistry is the most popular real-time 
chemistry employed to date.
A less expensive alternative to Taqman chemistry is using real-time PCR with an 
intercalating DNA dye such as SYBR green. SYBR green dye is similar to ethidium 
bromide and fluoresces only when bound to double-stranded DNA. Although SYBR 
green is a cheaper option, a major difficulty with this chemistry is that the dye fluoresces 
when bound to any double-stranded DNA products, including non-specific products.
Consequently to accurately quantify copy number with SYBR green, it is essential to 
optimize the reactions and amplify only the target o f interest. Although intercalating dyes 
are less specific, a quality control measure is available for this chemistry that is not 
available when using Taqman probes. A post-PCR melt curve analysis is a useful method 
to ensure a single PCR product is amplified with SYBR green. After amplification is 
complete, the temperature o f the thermal cycler increases incrementally over time. As the 
temperature increases any double stranded DNA denatures, releasing the fluorophores, 
and thereby producing a spike o f fluorescence. If  only one PCR product accumulates then 
only a single peak will be observed in the melt curve analysis. However, if  shorter PCR 
products are amplified such as primer-dimers two or more peaks will be visualized.
During real-time amplification the threshold cycle number (Ct) is the principal 
measure o f fluorescence. The Ct is the cycle number at which a significant increase in 
fluorescence is first detected. The threshold cycle number is correlated to the exponential 
growth phase o f PCR amplification. The Ct value is determined after a real-time PCR 
amplification and usually represents 10 times the fluorescent variance within the assay. 
The higher the initial amount o f target within a reaction, the sooner the accumulated 
product will be detected producing a lower Ct value. Therefore, by amplifying a series o f 
DNA standards o f known copy number and plotting copy number versus Ct values, a 
linear standard curve is produced (Fig. 1.2). This curve can then be used to quantify 
unknowns within the same run.
10
Correlation Coefficient: 1 .000 S lo p e :-3 .433  Intercept: 40.521 Y = -3 .4 3 3  X +  40 .521  
PCR Efficiency: 9 5 .6  %
°  Unknowns
o Standards
1 2 3 4 5 70 6 8
Log Starting Quantity, copy number
PCR Standard Curve: Data 08-Jul-04.opd
Figure 1.2: Quantification through real-time PCR. A series o f myosin standards with a 
known number o f  copies were amplified through real-time PCR indicated by the blue 
circles. The numbers o f standard copies (log quantity) are plotted against their respective 
threshold cycle values (Ct). The linear curve generated can then be used to estimate the 
initial copy number o f  unknowns that were amplified in parallel indicated by red squares.
Since real-time PCR enables a quick and reliable method by which to quantify the 
number o f target copies in an unknown sample, we developed two novel real-time PCR 
assays to determine both the proviral and plasma viral loads in infected cougars using 
both Taqman and SYBR green chemistries. Although real-time PCR is a sensitive 
method o f detection, the extensive divergence o f FIVpco may be a problem in accurately 
quantifying the amount o f virus in infected cougars. The viral diversity observed in 
cougars is known to be larger than the diversity observed in domestic cats (Carpenter et 
al., 1996). Nucleotide mismatches within the primer binding site have been shown to 
result in disparate amplification efficiencies between standards and unknowns (Klein et 
al., 1999). Moreover, a difference in amplification efficiencies between standards and 
unknowns can dramatically affect quantification (Leutenegger et al., 1999). Therefore,
11
the real-time PCR protocol was optimized to ensure proper amplification and accurate 
quantification.
Because FIV  is maintained as an endemic apathogenic infection in cougars, Puma 
concolor (FIVpco), we hypothesized that the lack of disease in cougars may be a result of 
diminished viral replication. To test this hypothesis, a real-time PCR assay was 
developed to quantify FIVpco proviral and plasma viral loads from infected cougars. The 
Specific Aims that were addressed in the research presented here:
Specific Aim 1: To develop a real-time PCR assay to quantify FIVpco proviral and 
plasma viral loads.
Specific Aim 2: To quantify proviral and plasma viral loads from peripheral blood 
mononuclear cells (PBMC), lymph nodes (LN) and plasma of infected cougars
12
Chapter 2
Establishment o f the FIVpco proviral and plasma viral load real-time PCR assay
In order to develop a real-time PCR assay that accurately quantifies FIVpco 
proviral loads in infected cougars, three main objectives must be accomplished. First, 
real-time primers must be designed to quantify both the number o f cell equivalents and 
the number o f FIVpco pro vial copies. Then the optimal primer concentrations for each 
primer set must be established experimentally. Finally, the real-time assay must be 
designed so that the plasmid DNA standards and the genomic unknowns amplify with 
equivalent efficiencies. After these three objectives are completed proviral loads can be 
accurately quantified from cougar PBMC and LN samples.
Primer Design
Primer design for quantitative RT-PCR is typically accomplished through a 
computer program from Applied Bioscience Inc. (ABI) called Primer Express. This 
program accounts for certain variables that inhibit efficient real-time amplification by 
selecting primers and probes according to the following set o f criteria. First, both the 
forward and reverse primer are designed to have a Tm, which is defined as the 
temperature at which 50 percent o f the primer concentration is bound to the target 
sequence, o f approximately 58 to 60°C. Additionally, the G-C content for each primer is 
designed to be between 20 and 80 percent and each primer does not have more than 40 
percent o f G ’s or C ’s at the 3’ end. Finally, the size of the real-time PCR amplicon is 
limited to between 50 and 150 basepairs (bp) because smaller amplicons give more
13
consistent results and are more efficiently amplified in real-time. While designing the 
probe two major criteria are addressed. First, the 5’ end o f the probe must not include a 
guanine because this nucleoside base acts as a natural quencher during amplification. 
Second the number o f G ’s cannot be greater than the number o f C ’s.
Proviral loads are typically calculated based upon the number o f viral DNA 
copies per million cell equivalents (Damond et al., 2001, Desire et al., 2001). Therefore, 
to quantify FIVpco proviral loads from infected cougar PBMC and LN, the number o f cell 
equivalents and the number o f FIVpco proviral copies must be determined for each 
genomic sample. In this assay a portion of exon 19 o f the cougar myosin gene was 
selected as our determinant for the number o f cell equivalents. Since this gene is well 
conserved in cougars, a Taqman primer and probe set was created that was 100% 
complementary to the myosin sequence. However, to quantify FIVpco copy number, no 
suitable Taqman probe could be designed because o f the extensive sequence divergence 
within FIVpco Previous FIVpco phylogenetic studies have established that distinct viral 
lineages o f  FIVpco exist within cougar populations in western North America and that the 
genetic diversity among cougar lentiviral lineages is greater than the diversity observed in 
FIV in domestic cats (Biek et al., 2003, Carpenter et al., 1996). Therefore, SYBR green 
chemistry was used for the quantification of FIVpco- The FIVpco primer set targeted a 
conserved region located at the 3 ’ end o f the putative env gene, which amplified a 170 bp 
fragment.
Construction o f plasmid DNA standards
14
After the myosin and FIVpco primer sets were identified through Primer Express, 
DNA plasmid standards were created for both myosin and FIVpco. In the case of myosin, 
genomic cougar DNA was PCR amplified using the real-time myosin primers. For the 
FIVpco DNA standards, cougar genomic DNA was amplified from five separate cougars 
that represented all FIVpco viral lineages. The PCR products for both myosin and FIVpco 
were subject to gel electrophoresis, gel purified, ligated into the pDrive vector and cloned 
(see Materials and Methods, Chapter 3). Plasmid DNA was purified and quantified 
through U V  spectroscopy. To determine the number o f copies for each DNA standard the 
following equations were used:
1) (bp size o f double-stranded product)(3 30 daltons x 2 nt/bp) = X daltons, 
(daltons = grams/mole)
2) (X grams/mole) / (6.023 x 10^  ̂molecules/mole) = X grams/molecule
3) Plasmid concentration (g/pl) / X grams/molecule = # o f molecules o f 
plasmid/pl
Rationale behind primer concentration optimization
Real-time PCR primer concentrations usually range from 50 to 900 nM. Therefore 
the optimal primer concentrations can be easily determined by independently varying the 
forward and reverse primer concentrations with a primer matrix as seen in Table 2.1. The 
primer concentrations that provide the optimal amplification are concentrations that yield 
the lowest threshold cycle number (Ct) and that produce no primer dimers. Primer dimer 
formation is unwanted in real-time PCR reactions because they are non-specific products 
and produce inaccurate results during quantification. Primer dimer formation can 
frequently be overcome by using unequal forward and reverse primer concentrations in 
the PCR reaction.
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During any real-time primer optimization it is recommended that all 
amplifications £ire done with SYBR green because o f two factors. First, SYBR green is a 
more economical choice during optimization than the Taqman probe. Second, with 
SYBR green a post-PCR melt curve analysis can be done for all reactions to determine 
whether any primer dimer formation has occurred. Non-specific products are o f major 
concern while using SYBR green chemistry because any nonspecific double stranded 
DNA products bind the intercalating dye and fluoresce during the PCR reaction. 
However, with Taqman chemistry the probe is created to specifically hybridize to the 
target sequence and therefore nonspecific products are not amplified. After the optimal 
primer concentrations have been established, the amount o f Taqman probe used for each 
reaction can be optimized. Probe concentrations usually range from 50 to 250 nM per 
reaction. Again the optimal probe concentration is the concentration that results in the 
lowest Ct value.
Optimization o f the myosin primers and probe
For the myosin primer optimization, a primer matrix (Table 2.1) was prepared and 
amplified with SYBR green with a single myosin standard at a concentration of 8x 10  ̂
copies per reaction. All reactions amplified (Fig. 2.1) and only a single peak was 
observed in the melt curve analysis (data not shown). The reactions that included the 
highest forward and/or reverse primer concentrations (900nM) produced the lowest Ct 
values, indicating that higher primer concentrations increased the robustness o f the real­
time reactions. However, in a separate amplification reaction, using four different myosin 
primer concentrations and cougar genomic DNA (1.0 ug) as a template, the primer
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concentrations o f 300nM forward and lOOnM reverse produced the lowest Ct value (Fig. 
2.2). All standards and genomic samples were run in duplicate and the average Ct values 
from the duplicate reactions were calculated to determine the threshold cycle number. 
Since the cougar myosin gene was to be quantified from genomic cougar DNA, it was 
sensible to choose the primer concentrations (300F/100R) that amplified the genomic 
cougar DNA more efficiently.
To determine the optimal myosin probe concentration, two separate plasmid DNA 
standards (8x10^ and 8x10^ copies per reaction) were amplified with the optimal myosin 
primer concentration (300F/100R) along with three different concentrations o f the 
myosin probe (50, 100, and 250nM per reaction). The Ct values obtained among all three 
probe concentrations for each plasmid DNA standard were not significantly different 
(data not shown). Therefore, the probe concentration was chosen to be 50nM per reaction.
Table 2.1: Primer Optimization Matrix
Reverse Primer (nM)
Forward Primer (nM)
100 300 900
100 1 0 0 /1 0 0 1 0 0 /3 0 0 1 0 0 /900
300 300 / 100 300 / 300 300 / 900
900 900 / 100 900 / 300 900 / 900
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Figure 2.1: Optimization o f the myosin primer concentrations. A single myosin DNA 
plasmid standard (8x10^ copies/reaction) was amplified through real-time PCR with 
different concentrations o f  both forward and reverse myosin primer indicated in the 
legend.
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□ 900F/100R
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Figure 2.2: Optimization o f  the myosin primer concentrations using cougar genomic 
DNA. 1 ug o f cougar genomic DNA was amplified through real-time PCR with four 
myosin primer concentrations indicated in the legend. The four myosin primer 
concentrations amplified the myosin plasmid DNA standards with different efficiencies.
Optimization results o f FIVpco primer set
18
To determine the optimal primer concentrations for the FIVpco primers, an 
identical primer matrix was amplified with a single FIVpco standard of 4x10* FIVpco 
copies per reaction utilizing SYBR green chemistry (Fig. 2.3). All reactions amplified 
and produced a single peak in the melt curve analysis (data not shown). The primer 
matrix identified three possible primer concentrations that most efficiently amplified the 
FIVpco plasmid DNA standard; 300F/300R, 100F/900R, 900F/900R. Because these three 
primer concentrations produced Ct values that were within two cycle numbers of each 
other and taking into account the amount o f primer used in each reaction, the primer 
concentration o f 300nM forward and 300nM reverse was subsequently chosen as the 
optimal FIVpco concentration.
FIVpco Primer Optimization
Primer C o n cen tra tio n s
□ 10OF/1 OOR
■ 300F /100R
□ 900F /100R
□ 100F/300R
■ 300F /300R
□ 900F /300R  
D 100F /900R
□  300R /900R
■  900F /900R
Figure 2.3: Optimization o f the FIVpco primer concentrations. A single FIVpco DNA 
plasmid standard (4x10* copies per reaction) was amplified through real-time PCR with 
different concentrations of both forward and reverse FIVpco primer indicated in the legend.
Investigating the accuracy of the real-time PCR quantification with the optimized myosin 
primer and probe concentrations
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Although both primer sets amplified a single PCR product, the accuracy o f the 
real-time assay needed to be determined. To this end, the myosin plasmid DNA standards 
were amplified in parallel to a series o f known genomic cougar DNA concentrations to 
quantify the number o f cell equivalents. Given that an animal cell contains 2 copies of 
DNA per cell and that animal genomic DNA weighs about approximately 1.9*10*^ 
daltons, a single cell contains six picograms o f DNA (Sambrook, 1989). Therefore, the 
theoretical number o f cougar cells within each reaction was calculated. The theoretical 
number o f cougar cells was then compared to the number o f cell equivalents quantified 
by the myosin real-time PCR assay (Table 2.2). We assumed that a single cell contains 
two copies o f  a gene, therefore, the number o f cell equivalents per reaction was 
calculated by dividing the number o f myosin copies quantified by real-time PCR by a 
factor o f two. The number o f cells was also enumerated prior to DNA purification, which 
supported the number o f theoretical cougar cells.
Table 2.2: Comparison o f the number o f cell equivalents quantified theoretically and 
through the myosin real-time PCR assay.
Concentration of 
cougar genomic DNA 
(ng/reaction)
Number of cell 
equivalents at 6 pg/ul 
(cells/reaction)
Number of cell 
equivalents from real­
time quantification 
(cells/reaction)
Fold difference 
between real-time 
and theoretical 
cell quantification
2.855x10^ 4.76x10® 2.33 x10^ - 2
2.855x10' 4.76x10® 4.26 x1Q4 8.9
2.855x10' 4.76x10' 2 .04 x10^ 4.3
2 855x10^ 5.0 2.3 x10^ 4.6
The results, which are summarized in Table 2.2, clearly indicate the numbers of 
cell equivalents in the three most dilute samples were all overestimated by more than a 
factor o f 4. However, the most concentrated sample (> 2.0 pg/reaction) did estimate the
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number o f  cell equivalents correctly. These results suggested that either the assay was 
optimized and DNA was lost or degraded in the most dilute samples prior to 
quantification or that the assay was not optimized and the most concentrated sample did 
not amplify efficiently.
Real-time quantification is known to be accurate between 0.1 and 1.0 pg o f DNA 
per reaction (ABI technical bulletin #43044490), which suggests that the most 
concentrated sample contained an excess amount o f DNA in the PCR reaction that 
inhibited real-time amplification. Moreover, additional experimental data indicated that 
when enumerating more than 10^ cell equivalents per reaction, amplification is not as 
efficient compared to genomic samples with less than 10  ̂cell equivalents per reaction 
(data not shown). Therefore, the most concentrated sample did not amplify properly 
indicating the quantification o f cell equivalents was incorrect based on the myosin 
standard curve and further optimization was necessary.
Since the quantification o f cell equivalents is based upon the myosin standard 
curve, the inaccurate quantification may be due to unequal amplification efficiencies 
between the DNA plasmid standards and the genomic unknowns. Therefore, the effect of 
carrier DNA and conformation of the plasmid DNA standards on real-time amplification 
was investigated.
Investigating the effect o f carrier DNA on real-time amplification
The effect o f  carrier DNA on real-time amplification was previously described in 
a real-time PCR assay that quantified FIV proviral loads in domestic cats (Leutenegger et 
al., 1999). This study determined that the Ct values of DNA plasmid standards decreased.
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on average 0.5 cycle numbers, with the addition o f carrier DNA. Moreover, the optimal 
carrier DNA concentration was determined to be 30 ng/reaction. Therefore, we 
investigated whether carrier DNA had an effect on the amplification of the myosin 
plasmid DNA standards.
To this end, a series o f  myosin DNA plasmid standards were serially diluted in 
the presence o f either no carrier DNA, carrier DNA at a final concentration o f 3 
ng/reaction or carrier DNA at a final concentration of 30 ng/reaction. The three standard 
curves were subsequently amplified simultaneously through real-time PCR (Fig.2.4). The 
results indicated that the Ct values o f all myosin plasmid DNA standards decreased 
approximately 5 cycles with the addition o f carrier DNA at a final concentration o f 30 
ng/reaction. Moreover, the influence o f carrier DNA on Ct values was greater in the DNA 
plasmid standards with the fewest number o f copies, which is to be expected due to 
reduced amount o f DNA in these low copy number standards. Carrier DNA alone did not 
amplify above threshold indicating the primer set was specific for myosin. The addition 
o f carrier DNA to the DNA plasmid standards was therefore included in our assay and 
the optimal concentration o f carrier was established to be 30 ng/ul.
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Figure 2.4: Effect o f carrier DNA on real-time PCR amplification. Three separate myosin 
standard curves, containing either 0, 3 or 30 nanograms o f carrier DNA per reaction, 
were evaluated simultaneously through real-time PCR. Each data point represents the 
average value o f duplicate reactions.
Investigating the effect o f linearizing plasmid DNA standards on real-time amplification
Since the addition o f carrier DNA influenced the amplification o f the DNA 
plasmid standards and the standards must amplify with equivalent efficiency in order to 
accurately quantify a sample, it follows that the environment o f the standards within the 
PCR reaction should mimic the environment of the unknowns. Given that cougar 
genomic DNA is linear and the plasmid DNA standards are circular, the amplification 
efficiencies o f the circular standards and genomic unknowns may be different. We 
therefore investigated the differences in Ct values between linearized and circular myosin 
DNA plasmid standards and the effect on quantifying the number o f  cell equivalents.
To understand the influence o f DNA conformation on amplification, plasmid 
DNA containing the myosin insert was linearized through a restriction digest with Xho I 
that cleaves the vector at a single site. The linearized DNA was then purified with the
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QIAquick PCR Purification Kit (Qiagen) and serially diluted (see Materials and Methods, 
Chapter 3). Circular and linear myosin DNA plasmid standards were amplified in parallel 
both containing carrier DNA at a final concentration o f 30 ng/ul (Fig. 2.5). In addition, 
serial dilutions o f cougar genomic DNA was quantified with both set o f standards.
The results indicated that the threshold cycle values were dramatically lower with 
linear DNA plasmid standards compared to the circular standards, suggesting that the 
linear DNA standards amplified more robustly (Fig. 2.5). The number o f theoretical cell 
equivalents (approximated at 6 pg/cell) was more appropriately quantified by the linear 
DNA plasmid standards, which exhibited only a 2-fold difference in the number of cell 
equivalents between the theoretical and real-time calculations (Table 2.3). The circular 
standards again overestimated the number o f cell equivalents by a factor o f ten. 
Consequently, all DNA plasmid standards were linearized prior to real-time amplification.
y = -3.3685X + 41.09 
= 0.9936o
-3.5507X + 39.544 
r2 = 0.999425
Circular myosin DNA 
standards
Linear myosin 
standards
Log Starting Quantity
Figure 2.5: Amplification o f circular and linear DNA plasmid standard curves. Two 
separate myosin standard curves, containing either circular or linear DNA plasmid 
standards, were amplified simultaneously through real-time PCR. Each data point 
represents the average value o f duplicate reactions.
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Table 2.3: Variation in quantifying the number of cell equivalents by using circular and 
linear DNA plasmid standards during real-time PCR.
Concentration 
of 
cougar 
genomic DNA 
(ng/reaction)
Theoretical number of 
cell
equivalents at 6 pg/ul 
(cells/reaction)
Number of cell 
equivalents 
quantified with circular 
plasmids (cells/reaction)
Number of cell 
equivalents 
quantified with linear 
plasmids 
(cells/reaction)
2.855x10= 4.76x10= 1.35x10= 2.94x10'
1.43x10= 2.38x1 o ' 1.98x10= 4.19x10'
7.14x10° 1.20x10= 1.07x10' 2.61x10=
3.57x10’ 5.95x10’ 3.95x10= 1.15x10=
Comparison o f amplification efficiencies between plasmid DNA standards and genomic 
unknowns
Finally to accurately quantify the number o f DNA copies in an unknown sample, 
the amplification efficiency o f the standards and unknowns must be equivalent. To 
determine whether the standards and unknowns amplify in the same way, the efficiency 
o f the reaction must be calculated. The efficiency o f a reaction is defined as and
identifies the number o f PCR products made during each cycle. To determine if 
amplification o f the plasmid standards and genomic DNA was equivalent, the myosin 
standard curve was compared to a 10-fold dilution series of cougar genomic DNA that 
spanned the range of genomic DNA concentrations used to estimate the number o f cell 
equivalents (Fig. 2.6). The efficiencies (defined as o f  the plasmid and genomic
samples were 1.90 and 1.91 respectively, indicating that plasmid and genomic DNA 
amplified with equivalent efficiency in our assay.
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Figure 2.6: Efficiency comparison between myosin plasmid DNA standards and cougar 
genomic DNA. A series of ten fold dilutions o f genomic cougar DNA was amplified in 
parallel to the myosin plasmid DNA standards to determine whether amplification 
efficiencies were equal. Efficiency is defined as
Optimization o f the FIVpco plasma viral load real-time PCR assay
FIVpco exists as a cell free RNA virus in the blood. Therefore, to properly quantify 
plasma viral loads in infected cougars, an additional reverse transcriptase (RT) step was 
required in the existing FIVpco real-time assay. The RT step necessitated the production 
o f RNA standards and confirmation that the RNA standards and unknowns amplified 
with equivalent efficiencies.
Viral genomic RNA was obtained by isolating viral particles from the supernatant 
o f a coculture o f infected cougar PBMC. Viral genomic RNA was subsequently purified 
and incubated with DNase to degrade any contaminating genomic DNA (see Materials 
and Methods, Chapter 3). Viral genomic RNA was quantified through UV 
spectrophotometry and the number o f genomic RNA copies was determined through the 
equation below:
1) (base size o f  full length genomic RNA (estimated at 9400b))(340 daltons) = 
3.196x10^ daltons, (daltons = grams/mole)
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2) (3.196x10^ grams/mole) / (6.023 x 10^  ̂molecules/mole) = 5.31'^* 
grams/molecule
3) RNA concentration (g/|il) / 5 . 3 grams/molecule = number o f RNA 
molecules/pl
After the number o f genomic RNA copies per microliter was determined, RNA standards 
were created through a series o f serial dilutions in DEPC-treated water.
Investigating the effect o f carrier RNA on RT real-time amplification
The effect o f carrier RNA on the amplification in the RT real-time assay was then 
investigated because o f two factors. First, carrier DNA dramatically influenced the real­
time amplification in the FIVpco proviral assay, indicating that the addition o f carrier 
played an important role in the real-time PCR assay (see above). Second, viral RNA 
purified from the plasma o f infected cougars is eluted in DEPC-treated water containing 
carrier tRNA (Sigma) at a final concentration o f 63 ng/pl to aid in recovery. Therefore, 
carrier RNA was added to the RNA standards to equalize the RNA concentrations 
between standards and unknowns. To determine whether exogenous RNA had an effect 
on amplification, two separate RNA standard curves were amplified in parrallel. One 
RNA standard curve included no carrier RNA and the other RNA standard included 
carrier RNA at a final concentration of 63 ng/pl.
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Figure 2.7: Effect o f carrier RNA on RT real-time assay. Two RNA standard curves were 
amplified in parallel, one with carrier RNA and one lacking carrier RNA.
The results indicated that carrier RNA had a greater effect on the amplification 
efficiencies o f the RNA standards than the plasmid DNA standards (Fig. 2.7). The more 
dilute RNA standards, which did not contain any carrier RNA, did not amplify. These 
data suggest that either viral RNA was lost during the dilution steps or that the more 
dilute RNA standards were not efficiently reverse transcribed. For these reasons the 
addition o f carrier RNA was necessary in the RT real-time PCR assay. Carrier RNA 
alone did not amplify above threshold. Therefore, the viral RNA standards and the viral 
RNA obtained from the plasma of infected cougars contained the same carrier tRNA 
concentrations in order to equalize the efficiency o f reverse transcription and subsequent 
amplification.
Comparison o f amplification efficiencies
Finally to determine whether the RNA standards and plasma unknowns amplified 
with equal efficiency, three ten fold dilutions o f plasma RNA from a single cougar were 
amplified in parallel with the RNA standards (Fig. 2.8). The results indicated that the
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standards and unknowns amplified with comparable efficiency, 2.02 and 1.88 
respectively. The estimated log starting quantities of all three serial dilutions were similar. 
The range was from 4.5 to 4.85 log starting RNA copies per ml. However, the most dilute 
plasma unknowns amplified with decreased efficiency. Therefore, the total amount of 
plasma from each cougar was concentrated through ultracentrifugation prior to 
amplification to aid in real-time detection.
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Figure 2.8: Efficiency comparison o f RNA standards and plasma unknowns. RNA 
standards were amplified in parallel with serial ten fold dilutions o f plasma from an 
infected cougars, YM131, to determine whether amplification efficiencies were equal. 
Efficiency is defined as
The optimized conditions for the real-time FIVpco proviral and plasma viral load 
assays were subsequently employed to quantify viral loads from a large representative 
group o f infected cougars.
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Chapter 3
M anuscript entitled Quantification o f Feline Immunodeficiency Virus (FIVpco) in 
peripheral blood mononuclear cells, lymph nodes and plasma of naturally infected
cougars
Introduction
Feline immunodeficiency virus (FIV) is a lentivirus that infects members o f the 
Felidae family worldwide. Although all FIV strains detected in wild and domestic cats 
form a monophyletic cluster in a phylogeny o f lentiviruses, each feline species is infected 
with a distinct virus and infection results in disparate outcomes (Burkhard & Dean, 2003). 
FIV is maintained as an apathogenic infection in some members o f the cat family such as 
lions {Panthera led) and cougars {Puma concolor) (Brown et al., 1994, Carpenter & 
O'Brien, 1995, Olmsted et al., 1992). However, FIV infection in domestic cats results in a 
disease similar to HIV-1 in humans that begins with an acute illness and progresses to 
immunodeficiency and ultimately death (Bendinelli et al., 1995, Pedersen et al., 1987).
The amount o f circulating virus is a strong prognostic indicator for disease 
progression in FIV and HIV-1 infections (Goto et al., 2002, Mellors et al., 1996). In both 
naturally and experimentally infected domestic cats, FIV replicates to high titers and 
elevated viral loads are associated with shorter survival time and progression to feline 
AIDS (Diehl et al., 1996, Goto et al., 2002). Similarly, high plasma virus loads are 
associated with disease progression in HIV-1 (Mellors et al., 1996).
African primates are also host to lentivirus infections (simian immunodeficiency 
virus, SIV) and, as is the case with endemic feline lentivirus infections, there is no
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evidence o f  disease (Beer et al., 1996, Broussard et al., 2001, Chakrabarti et al., 2000). 
However, plasma virus loads in African green monkeys (Cercopithecus aethrops) and 
sooty mangabeys (Cercocebus ayts) naturally infected with SIVagm and SIVsm, 
respectively, are on the order o f 10^ RNA copies per ml (Broussard et al., 2001, 
Chakrabarti, 2004). These data indicate that virus replication can be robust even in 
asymptomatic infections and thus high levels o f circulating virus are not always 
associated with disease.
Currently, no viral load data have been determined for endemic FIV infections in 
wild felids. FIVpco infects free-ranging cougars in North and South America with 
infection prevalence averaging 30% (Carpenter et al., 1996), but reaching as high as 58% 
in some populations in the Western United States (Biek et al., 2003). This prevalence is 
remarkable because cougars are solitary carnivores with infrequent conspecific contacts. 
Intrahost viral diversity is less than 1% in infected cougars and the evolutionary rate of 
FIVpco has been estimated at 0.1-0.3%/site/year (Biek et al., 2003). This is an order of 
magnitude lower than the estimated rate o f 3%/site/year reported for SIVagm (Muller- 
Trutwin et al., 1996) or 1 %/site/year for HIV-1 (Leitner & Albert, 1999, Poss et al., 2004, 
Shankarappa et al., 1999). The faster evolutionary rate o f SIV and HIV-1 could be due to 
increased viral replication resulting in a rapid accumulation of mutations and stronger 
selection on the virus population. Therefore, based on the lack o f disease, the low 
intrahost viral diversity and low evolutionary rates, we hypothesized that viral loads in 
cougars would be lower than in pathogenic FIV and HIV-1 infections or in endemic SIV 
infection in primates. We subsequently developed a real-time PCR assay for FIVpco and
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used the assay to determine the amount o f virus present in a large set o f naturally infected 
cougars.
Methods
Study Population and Cougar Samples
Peripheral blood mononuclear cells (PBMC), lymph nodes (LN) and plasma 
samples used in this study were obtained from free-ranging cougars from four Rocky 
Mountain populations previously determined to be infected with FIVpco- Genomic DNA 
samples from PBMC were obtained from 39 infected cougars. Genomic DNA samples 
from LN were obtained from a group o f 10 hunter-killed animals submitted to the 
Montana Department o f Fish, Wildlife, and Parks. Plasma samples were also obtained 
from 32 infected cougars. Genomic DNA was extracted from samples as previously 
described (Biek et al., 2003).
Phylogenetic analysis
A fragment o f proviral env was amplified from serial dilutions o f PBMC or lymph 
node DNA from all infected cougars evaluated in this study. PCR products were cloned 
and sequenced as previously described (Biek et al., 2003). Alignments were conducted in 
Lasergene (version 5.5) from DNASTAR, Inc (Madison, WI) using the CLUSTAL W 
algorithm. A maximum likelihood (ML) tree was created in PAUP* (4.10b; Sinauer 
Associates, Inc.) (Swofford, 2002) using a GTR+I+G model as determined in Modeltest 
(Posada & Crandall, 1998). PLY 1695 (AY307116) was used as an outgroup (Biek et al., 
2003). 100 bootstrap iterations were performed. One env sequence for each cougar has
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been submitted to Genbank under accession numbers A Y l20787, AY120790, 
AY120793-94, AY120798-802, A Y l20804-810, AY120812, AY120815, D Q 106994-97, 
D Q 106999-00, DQ107003-06, DQ107052-54, DQ 107056-60 and DQ 107062-68.
Sequence analysis o f the real-time FIVpco amplicon
A 690 bp fragment o f proviral FIVpco was amplified by nested PCR from DNA 
derived from PBMC o f 14 infected cougars, which included representatives of each viral 
lineage. The oligonucleotides used for the first round were Co7990F (5’- 
ATGCAAGTTATGAGATGTAG-3’ and Co8958R (5’-TTATTCAACCGTTCGCACTT- 
3 ’). The oligonucleotides used for the second round were Co3LTRF (5’- 
ACGGCCTTAGTGGTGTCTCAG-33  and Co8859R (5’-
CCATTCCTCCCAGTCTACCC-3’). The conditions for the first round o f PCR were as 
follows: 3 min at 94°C followed by 35 cycles o f 94°C for 30 sec, 48°C for 30 sec, 71 °C 
for 70 sec and followed by a 5 min extension at 71°C. The conditions for the second 
round o f PCR were as follows: 3 min at 94°C followed by 35 cycles o f 94°C for 30 sec, 
51°C for 30 sec, 71°C for 45 sec and followed by a 5 min extension at 71 °C. The PCR 
products were cloned into the pDrive plasmid (Qiagen, Veiencia, CA) and sequenced.
Plasma Viral RNA Preparation
Plasma or serum samples were centrifuged for 1.5 h at 100,000 x g. The viral 
pellet was resuspended in 140 pi PBS containing Ca^^ and Mg"^  ̂and incubated for 1 h 
with DNase. RNA was purified using the QIAamp viral RNA mini kit (Qiagen) and
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eluted in 30 |il DEPC-treated water. Plasma volumes greater than 2 ml were eluted in 60 
|il. Samples were stored at -80°C for cDNA synthesis.
Preparation o f DNA and RNA real-time PCR Standards
A plasmid standard for myosin was constructed by amplifying a 220 bp fragment 
o f cougar genomic DNA with primers designed to exon 19 o f the cougar myosin gene. 
The primers used were MyoF (5’-CAAGAACTGGCCCTGGATGAA-3’) and MyoR (5’- 
CTGCACTTGGAGCTGGAGGTC-3’). The conditions for the PCR were as follows: 3 
min at 94°C followed by 30 cycles o f 94°C for 30 sec, 52°C for 30 sec, 71 °C for 50 sec 
and followed by a 5 min extension at 71°C. The PCR product was cloned into the pCR4- 
Topo plasmid (Invitrogen, Carlsbad, CA). A 690 bp fragment o f the FIVpco genome near 
the 3’ end o f env was amplified by PCR from cougar proviral DNA as described above. 
All plasmids were linearized and purified with the QIAquick PCR Purification Kit 
(Qiagen). Plasmid concentration was determined by UV spectroscopy. All DNA plasmid 
standards were diluted in 10 mM Tris containing salmon sperm DNA (Sigma-Aldrich, St. 
Louis, MO) as a carrier at a final concentration o f 6 ng/pl.
Virus from the supernatant o f a coculture o f  3201 cells and PBMC of a naturally 
infected cougar, SRF631, was used for the RNA standards. Viral RNA concentration was 
determined by UV spectroscopy to estimate copy number. All RNA standards were 
diluted in DEPC-treated water and carrier tRNA (Sigma) at a final concentration o f 63 
ng/pl. The viral RNA standards and viral RNA obtained from the plasma o f infected 
cougars contained equivalent carrier tRNA concentrations.
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FIVpco Real-time PCR Quantification
TaqMan chemistry was used to quantify the number of cell equivalents in each 
proviral reaction. For the myosin reactions, the primers used were MyoTaqMF (5’- 
TGGCCCTGGATGAAACTCTACT-3’) and MyoTaqMR (5’-
GCCATCTCCTTCTCGGTCTCT-3’). The probe sequence used for this primer set was 
Myoprobe (5 ’-FAM-CAAGATCAAGCCCCTCCTCAAGAGCG-TAMRA-3’).
SYBR green chemistry was used for quantification of FIVpco from genomic DNA 
and plasma because sequence divergence among FIVpco lineages precluded designing a 
suitable probe. The primers used were ETaqF (5’-TGATCCTGATGCTCCACCAAC-3’) 
and ETaqR (5’-TCTCACTCTGTTCTGCCCATT-3’)- The amplification with this pair of 
oligonucleotides produced a fragment o f 170 bp.
Reactions consisted o f 25 pi o f the 2X Universal Master Mix (Applied 
Bio systems, Foster City, CA) containing 100 mM KCl, 40 mM HCl Tris, 1.6mM dNTP, 
50 Units/pl Taq, 6 mM M gCli and 5 pi o f genomic template, in a 50 pi total reaction 
volume. Each myosin reaction contained 300 nM MyoTaqMF, 100 nM MyoTaqMR and 
50 nM Myoprobe. Each FIVpco proviral reaction contained 300 nM ETaqF, 300 nM 
ETaqR and 1:10000 dilution o f SYBR Green I gel stain (BioWhitaker, Walkersville, 
MD).
Myosin amplification was 1 cycle o f  95°C for 10 min followed by a two-step 
PCR procedure consisting o f 95°C for 15 sec then 60°C for 1 min for 45 cycles. FIVpco 
amplification was similar except that the annealing temperature was 61 °C for 1 min. 
Amplification, data acquisition and analysis were performed using the iCycler real-time 
PCR detection system (BioRad, Hercules, CA). All FIVpco reactions were evaluated by
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melt curve analysis to confirm the size of the amplicon and lack o f primer dimer 
formation. Genomic DNA from uninfected cougars did not amplify with FIVpco specific 
oligonucleotides.
Reverse transcription (RT)-PCR was carried out as a two-step procedure for both 
the RNA standards and plasma samples. The reaction mixture, 30 pi total, contain 1 pi 
Superscript'^^ III Reverse Transcriptase (Invitrogen), 4 pi 5X RT buffer, 1 nM ETaqR 
and 10 pi purified RNA. The reaction was conducted at 50°C for 50 min. and 85°C for 5 
min.
Plasma viral RNA quantification was determined using 50 pi reactions consisting 
o f 25 pi 2X Platinum SYBR Green qPCR SuperMix (Invitrogen), 300 nM ETaqF and 
300 nM ETaqR. FIVpco amplification was 1 cycle o f 50°C for 2 min followed by 1 cycle 
o f 95°C for 2 min then a two-step PCR procedure consisting of 95°C for 15 sec then 
60°C for 45 sec for 45 cycles.
All standards, negative controls and samples were run in duplicate and the 
average value o f the copy number was used to quantify both FIVpco and myosin. The 
measurements o f myosin and FIVpco copy numbers were accepted if  the coefficients o f 
variation (CV) were <20% for myosin reactions and <35% for FIVpco reactions. FIVpco 
copy number for provirus was divided by the number o f cells assayed and reported on the 
basis o f 10^ PBMC or LN cells. FIVpco copy number for plasma virus was divided by the 
volume o f plasma assayed and reported as the number o f viral RNA copies per milliliter 
o f plasma.
Statistical Analysis
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The lower limits o f detection for the proviral and plasma viral load real-time PCR 
assays were set at 100 DNA copies and 320 RNA copies per reaction to account for 
increased variability in cycle number in quantifying low copy numbers (see Results). 
Samples that amplified below the lower limit o f detection were confirmed by melt curve 
analysis.
Proviral and plasma viral loads were determined from PBMC and plasma that 
were above the lower limit o f detection. The mean and standard deviation o f both 
proviral and plasma viral loads were calculated. 95% confidence intervals were then set 
for both population means through the Student’s t distribution. The lower limit o f both 
proviral and plasma viral loads was calculated. The minimum number o f cell equivalents 
and minimum volume o f plasma per reaction, which would generate viral loads within 
the 95% confidence intervals, were determined to be 1.16x10^ cells and 100 pi plasma 
per reaction. Samples assayed that exceeded the calculated minimum o f cell equivalents 
or plasma volume, but had viral loads below the lower limit o f real-time detection, were 
down weighted with a factor o f 1/VlO to account for increased variability in threshold 
cycle numbers at low copy number. Proviral and plasma samples assayed below the 
calculated minimum o f cell equivalents or plasma volume and samples that did not reach 
threshold were excluded from the statistical analysis.
A weighted univariate analysis o f covariance (ANCOVA) was used to test if  any 
significant differences existed among the logio proviral and plasma viral load means due 
to differences in age, gender and lineage. Levene’s test o f equality o f error variance was 
used to ensure equal variance existed across the lineages. The proviral model was created
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based on the ANCOVA o f proviral load on age, which resulted in separate slopes and 
intercepts for each lineage.
Results
Experimental conditions o f the FIVpco proviral and plasma viral load real-time PCR 
assays
A fragment o f exon 19 o f the cougar myosin gene was used to determine the 
number o f  cell equivalents in samples to be quantified for FIVpco pro virus. Amplification 
o f the myosin standard curve was based on Taqman chemistry and was linear over seven 
orders o f magnitude. To determine if  amplification o f the plasmid standards and genomic 
DNA was equivalent, the myosin standard curve was compared to a 10-fold dilution 
series o f cougar genomic DNA that spanned the range o f genomic DNA concentrations 
used to estimate the number o f cell equivalents (data not shown). The efficiencies 
(defined as o f the plasmid and genomic samples were 1.90 and 1.91 respectively,
indicating that plasmid and genomic DNA amplified with equivalent efficiency in our 
assay. The number o f cell equivalents determined for proviral quantifications was 
established by calculating the mean o f two separate myosin quantifications of genomic 
cougar DNA.
The inter-assay variation for myosin quantification was determined by comparing 
the values obtained for standard curves amplified in four separate experiments. Five 
standards with the lowest copy number (9.25x10"* to 9.25x10^ copies per reactions) were 
used in calculating the CV to measure the variation in the most dilute standards (data not
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shown). The average threshold cycle (Ct) CV was 1.04% and the average absolute CV 
was 14.52%. These results demonstrate that the assay used to enumerate cell equivalents 
is highly reproducible.
Previous work established that mismatches within the real-time primer sites do 
not enable accurate quantification because of variable efficiencies in amplification (Klein 
et al., 1999, Leutenegger et al., 1999). Therefore, since the viral sequence diversity 
observed among cougar lentiviurses is greater than the diversity observed in FIV in 
domestic cats (Carpenter et al., 1996), we considered it necessary to first establish the 
phylogenetic affiliation o f all FIVpco samples prior to quantification and then determine 
the effect o f  nucleotide mismatches on FIVpco real-time amplification. All samples 
clustered within five distinct viral lineages based on a fragment o f env (Fig. 3.1). Viral 
lineage associations were consistent with those in a ML tree of 150 individual cougar 
sequences from data sets based on env and po l (unpublished data). The associations of 
lineage one and two were consistent with previously published results (Biek et al., 2003, 
Carpenter et al., 1996). The sequence variation in the FIVpco amplicon primer sites was 
then determined from a representative subset o f infected cougars from each viral lineage 
(Fig. 3.2). The viral sequence from lineage four was an exact match to the primers. The 
sequences from lineage one and three had the same single mismatch in the reverse primer. 
The standard from lineage two had a single mismatch in the forward primer and the 
standard from lineage five had single mismatches in both the forward and reverse primer 
sites.
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Figure 3.1: Phylogenetic relatedness o f FIVpco based on env. An estimate o f the 
phylogenetic relationship o f partial FIVpco env sequences from naturally infected cougars 
based on maximum likelihood. The values next to the tree nodes represent bootstrap 
values o f > 70 based on 100 bootstrap iterations. PLV was used as an outgroup. The 
population affiliation and sex for each cougar is indicated before the animal identification
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number (Y, Yellowstone National Park, MT; SR, Snowy Mountain Range, WY; Gc, 
Garnet Mountain Range, MT; Jc, Jackson Mountain Range, WY). Sequences used in 
real-time proviral quantification as plasmid DNA standards are indicated by *.
E T A QF  T G A T C C T G A T G C T C C A C C A A C
G C 3 4   A .....................................................................................
G c F 6 0   A .....................................................................................
G c 7 0   A .....................................................................................
Y M 1 3 7  ......................................................................................................................................
Y F 1 2 4  ......................................................................................................................................
Y M 1 6 3  ......................................................................................................................................
J M O l  ......................................................................................................................................
Y F 1 2 5  ......................................................................................................................................
Y M 1 4 8  ......................................................................................................................................
6 3 1   T .............................................
6 0 4   T .............................................
6 2 2  C .................................................................................................................................
6 0 3 B  ......................................................................................................................................
6 2 7  ......................................................................................................................................
ET AQR A A T G G G C A G A A C A G A G T G A G A
GC3 4  A .
G c F 6 0   A .
G c 7 0   A .
Y M 1 3 7  ......................................................................................................................................
Y F 1 2 4  ......................................................................................................................................
Y M 1 6 3  ......................................................................................................................................
J M O l  ......................................................................................................................................
Y F 1 2 5   G .............................
Y M 1 4 8   G ..............................
6 3 1  ......................................................................................................................................
6 0 4  .......................................................................................................................................
6 2 2   G ..............................
6 0 3 B   G ..............................
6 2 7   G ..............................
Figure 3.2: Sequence variation o f FIVpco in the forward and reverse primer sites. The 
alignment shows the number of nucleotide mismatches within the primer sites from a 
representative subset o f naturally infected cougars for each viral lineage. Both primer 
sequences are shown in the sense orientation. Dots indicate match with the primer 
sequences.
We prepared separate FIVpco standards from sequences that represented each viral 
lineage and investigated the effects o f these mismatches on amplification efficiency. 
Lineage standards containing no mismatches, or mismatches in one or both primers were 
evaluated simultaneously by real-time PCR. Standards from three lineages produced 
overlapping curves (Fig. 3.3a) and were not significantly different based on a F  test for 
significant differences between lines (P = 0.114). Although the differences between DNA
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plasmid standard curves were not significantly different, the error associated with the low 
copy number standards increased with the number o f primer mismatches. Therefore, for 
proviral DNA quantification, a lineage specific standard was used for samples of each 
lineage.
The average Ct CV (3.62%) and the average absolute CV (38.52%) was 
calculated to determine FIVpco inter-assay variation (Fig. 3.3b). The inter-assay variation 
o f the FIVpco real-time assay was greater than the difference between different FIVpco 
lineage standards. The average absolute FIVpco inter-assay variation, obtained with SYBR 
green, o f 38.52% is comparable to the variation previously described in real-time assays 
using Taqman probes, which has been reported to be greater than 35% (Damond et al., 
2001, Desire et al., 2001). As seen in Figure 3.3b, the coefficient o f variation increased at 
the lowest copy numbers, where the final standard, 6.45x10^ copies, had the largest CV 
value (68.33%). Subsequently, we set the lower limit o f detection at 100 DNA copies per 
reaction to account for the variability associated with the most dilute standard.
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GcF34 2.04 1 for / 1 rev 489 53.8%
SRM622 1.99 1 rev 939 11.4%
YM137 1.96 None 1060 N/A
B
Copy Number 
per reaction
Ct mean SD %CV Abs mean SD %CV
6.45X10" 20.04 0.95 4.72 798220 210341 26.35
6.45X10^ 23.27 0.72 3.08 78042 22146 28.38
6.45X10^ 26.59 0.86 3.22 7468 2979 39.89
6.45X10^ 30.24 0.83 2.74 515 153 29.71
6.45X10' 33.21 1.45 4.36 60 41 68.33
Figure 3.3: Real-time FIVpco proviral standard curves and inter-assay variation. A) A 
comparison o f FIVpco DNA standard curves amplified from plasmid standards 
representing three viral lineages. The amplification efficiency and the number of primer 
mismatches are indicated for each standard. Copy number at Ct = 30 denotes the number 
o f  proviral copies calculated from each plasmid standard curve at threshold cycle 30. B) 
The inter-assay variation in the SYBR green proviral quantification assay was determined 
for the most dilute standards in order to establish the effect o f low copy number on inter­
assay variation. Ct mean = mean value for threshold cycle number, SD = standard 
deviation, %CV = coefficient o f variation expressed as a percentage, Abs mean = mean 
value for absolute copy number.
For plasma viral load quantification, a two-step real-time PCR assay was 
developed that was linear over six orders o f magnitude from 3.2x10^ to 3.2x10^ copies 
(Fig. 3.4). The lower limit o f  detection for this assay was set at 320 RNA copies per 
reaction to account for increased variation in threshold cycle number with low copy
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number standards. Only one RNA standard was amplified in the real-time reverse 
transcription (RT) assay because there were no significant differences between separate 
proviral standards in amplification and virus representative o f all five lineages have not 
been isolated. Because we did not know a priori if  we would detect any circulating virus 
in cougar blood, the total amount o f plasma was concentrated by ultracentrifugation 
before RNA isolation to aid in detection. Standards and samples were reverse transcribed 
simultaneously to ensure similar RT efficiencies within an assay. The inter-assay 
variation for RT real-time PCR was 3.92% for the average Ct CV and 38.38% for the 
average absolute CV (Fig. 3.4). This is similar to the inter-assay variation for the proviral 
quantification suggesting that the RT step had minimal effects on assay reproducibility 
and is also comparable to variation reported for other real-time RT assays (Gibellini et al.. 
2004, Gueye et al., 2004).
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Copy Number 
per reaction
Ct mean SD %CV Abs mean SD %CV
3.2X10^ 25.44 0.76 2.99 4050897 1446616 35.71
3.2X10" 29.51 1.18 3.99 231206 61939 26.79
3.2X10^ 32.40 1.12 3.45 30121 9216 30.60
3.2X10^ 34.49 1.49 4.31 6825 3484 51.05
3.2X10^ 40.50 1.96 4.85 199 95 47.74
Figure 3.4: Real-time FIVpco RNA standard curve and inter-assay variation. The RNA 
standard curve shown is from a representative two-step SYBR green RT-PCR real-time 
experiment. The inter-assay variation o f the two-step SYBR green RT real-time assay 
was determined for the most dilute standards in order to establish the effect o f low copy 
number on inter-assay variation. FIVpco genomic RNA was prepared from the supernatant 
o f a coculture of PBMC from SRF631, a cougar infected with a lineage 1 virus, and a 
domestic cat cell line.
Proviral Loads in naturally infected cougars
Cougar samples quantified in this study were previously determined to be FIVpco 
positive by nested PCR. Therefore, the FIVpco real-time PCR assay was utilized only to 
quantify viral loads and was not used as a detection method. Thirty-nine cougar PBMC 
samples were quantified and 22 (56%) were within our level o f detection. Ten lymph 
node (LN) samples were also quantified and five were within the range of detection 
(50%). Samples that had less than 100 proviral copies, which we established as the lower 
limit o f detection, were still valuable in our analysis. For example, FIVpco copy number 
was below the limit o f detection in four PBMC and two LN samples despite the fact that 
more than 1x10^ cell equivalents were assayed, indicating that the proviral load was low 
in those animals. Therefore, 95% confidence intervals for the number o f cells required for 
FIVpco detection was established (see Materials and Methods). Samples that were 
adequately assayed but below detection were down weighted to account for increased
45
variability associated with threshold cycle number. Eight PBMC samples were down 
weighted in the proviral analysis. Samples for which there were insufficient cell numbers 
or plasma volume for adequate sampling were omitted from the statistical analysis. Nine 
PBMC samples were omitted from the proviral analysis.
The mean proviral load per 10^ PBMC was 1.34x10"^ and ranged from 2.9x10^ to 
6 . 7 2 x 1 (Fig. 3.5). The lowest proviral loads were adequately assayed, however, the 
number o f proviral copies quantified was below our limit o f detection. Therefore, these 
samples were down weighted. The mean proviral load per 10^ lymph nodes cells was 
1.51x10^ (range 8.06x10^ to 2.51x10^). These data indicate that an average of 1 in 75 
circulating cells is infected with FIVpco and 1 in 66 cells in the lymph nodes are infected.
We tested the hypothesis that average proviral loads in PBMC were equal among 
gender, age and lineage using a weighted ANCOVA. These factors were considered 
because one or all may have a significant biological effect on the amount o f virus in 
infected cougars. Previous experimental FIV infections established that the amount o f 
virus in domestic cats differs significantly between different field isolates (Pedersen et al.. 
2001). Therefore, it was important to understand whether these factors influence viral 
loads in natural endemic FIV infections. The variation in proviral load was determined to 
be equal across lineages through Levene’s test o f equality o f error variance {P = 0.239). 
Proviral loads were significantly different between lineages (P = 0.029) and there was a 
significant interaction between viral lineage and cougar age, indicating that these 
variables considered together had an effect on proviral load (P = 0.014). No correlation 
was observed between proviral load and gender (P = 0.440).
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Univariate analysis o f covariance demonstrates whether differences between 
means are statistically significant but not how means differ. Therefore, to understand the 
influence o f age and lineage on proviral loads, the linear regression from the ANCOVA 
o f proviral load on age was conducted to model the change in lineage specific proviral 
loads versus age, which resulted in separate curves for each lineage (R^ = 0.549) (Fig.
3.6). Cougars infected with viruses from either lineage one or two have an increase in 
PBMC proviral loads with age. In contrast, cougars infected with viruses from either 
lineage three, four or five exhibit a decrease in proviral loads with age. The linear 
regression of proviral loads from lineages one and two were statistically different from 
those o f lineages three, four and five {P < 0.05). However, the differences observed 
between lineages three, four and five were not significant {P > 0.24).
Plasma Viral Load in naturally infected cougars
Thirty-two plasma samples were quantified and in 21 (66%) of these samples 
FIVpco was detectable in our real-time assay. The plasma viral loads ranged from 
2.30x10^ to 2.81x10^ RNA copies per ml, with a mean o f 5.69x10^ (Fig. 3.5). O f the 11 
plasma samples that were below our limit o f detection, eight samples were not included 
in the statistical analysis because an insufficient volume o f plasma was assayed and three 
samples were down weighted as previously described. The variance in plasma viral loads 
was determined to be equal across lineages through Levene’s test {P = 0.086). Moreover, 
through a univariate ANCOVA, no significant differences were observed between mean 
plasma viral loads for different genders, ages or lineages {P = 0.958, 0.830 and 0.783 
respectively). Additionally, we were able to quantify proviral and plasma viral loads from
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the same blood sample of 11 cougars in the study (Fig. 3.7). As is evident from Figure 6, 
no correlation was observed between proviral and plasma viral loads value = 0.133). 
These data demonstrate that FIVpco infected cells produce variable amounts o f virus in the 
blood, which is not correlated to the number o f infected PBMC, age, gender or viral 
lineage.
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Figure 3.5: FIVpco proviral and plasma viral load for each viral lineage. The average 
values for each viral lineage are shown next to the horizontal lines. Closed shapes denote 
proviral or plasma viral loads that were within the detection limits established for this 
assay. Open shapes denote down weighted proviral or plasma viral loads.
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Figure 3.6: A weighted analysis o f covariance o f cougar PBMC proviral loads versus 
cougar age. The colors for each viral lineage correspond to the phylogeny displayed in 
Fig. 1. The change in lineage specific proviral loads versus cougar age was based on an 
ANCOVA o f cougar PBMC proviral loads with viral lineage and gender as factors and 
age as a covariate. Lineage specific PBMC proviral loads were averaged across gender 
because gender was not a significant influence on PBMC proviral loads. The linear 
regressions o f  proviral loads from lineages one and two, indicated with A, were 
statistically different from those o f lineages three, four and five {P < 0.05). However, the 
differences observed between lineages three, four and five, indicated with B, were not 
significant {P > 0.24).
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Figure 3.7: Correlation o f cougar PBMC proviral loads versus plasma viral loads of 
infected cougars. Proviral and plasma viral loads were quantified from the same blood
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sample o f  11 cougars. All samples had at least one viral load parameter that was within 
the detection threshold. Diamonds denote proviral and plasma viral loads within the 
detection threshold. Down weighted proviral loads are indicated with ‘x ’ and denotes 
down weighted plasma viral loads.
Discussion
Free-ranging cougars are one o f many feline species that harbor an endemic 
lentivirus infection without any apparent signs o f disease (Carpenter & O'Brien, 1995, 
Olmsted et al., 1992, Troyer et al., 2004). However, it was not known if  the lack of 
disease observed in naturally infected cougars was a result o f low level viral replication. 
Consequently, FIVpco proviral and plasma viral loads were quantified from naturally 
infected cougars through a recently developed real-time PCR assay. This study represents 
the most extensive analysis o f  proviral and plasma viral loads in natural, endemic 
lentivirus infections to date.
Proviral loads previously reported in infected PBMC from African green monkeys 
and sooty mangabeys are on the order o f 10^ to 10  ̂proviral copies per 10  ̂cells, 
respectively (Beer et al., 1996, Broussard et al., 2001, Chakrabarti, 2004, Muller & 
Barre-Sinoussi, 2003, Rey-Cuille et al., 1998). The average cougar PBMC proviral load 
was 1.34x10"* proviral copies per 10^ cells. Therefore, FIVpco proviral loads in infected 
PBMC are an order o f magnitude higher than in PBMC from infected primates. The 
average LN proviral load, which was determined from a separate group o f infected 
cougars, was 1.51x10"* proviral copies per 10^ cells. Although the variation around LN 
proviral loads was markedly lower than in PBMC, both cougar PBMC and LN cells had 
similar average proviral loads. Equivalent PBMC and LN proviral loads have been 
previously reported in a large cohort o f long-term naturally infected AGM (Beer et al.,
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1996). These data stand in contrast to other studies that have reported elevated proviral 
loads in lymphoid tissue in naturally infected primates and HIV-1 infected humans 
(Broussard et al., 2001, Fauci et al., 1996, Rey-Cuille et al., 1998). Finally, plasma viral 
loads in naturally infected cougars ranged from 10^ to 10^ RNA copies per ml and are 
comparable to viremia levels previously reported in SlVsm and SIVagm infections 
(Broussard et al., 2001, Goldstein et al., 2000, Holzammer et al., 2001, Rey-Cuille et al., 
1998). These data clearly indicate that the absence o f detectable disease in naturally 
infected cougars and primates is not a result o f low level viral replication.
In epidemic lentivirus infections, such as HIV-1 or FIV in domestic cats, the 
amount o f circulating virus is an accurate predictor o f disease severity. In humans and 
domestic cats, plasma viral loads greater than 10  ̂copies per ml are correlated to disease 
progression and shorter survival time (Diehl et al., 1996, Goto et al., 2002, Mellors et al.,
1996). FIVpco infected cougars maintain plasma viral loads that are greater than 10  ̂
copies per ml during infection, but these animals remain asymptomatic. Since elevated 
plasma viral loads in infected cougars are not associated with disease, we determined 
whether FIVpco plasma viral loads were influenced by factors such as age, gender or viral 
lineage. However, no significant differences were observed. The lack of correlation in 
plasma viral loads to these factors may reflect the transient nature o f cell-free virus 
compared to the integrated pro virus. Different rates of cell-free virus clearance and 
production have been reported in patients infected with HIV-1, but the lifespan of 
infected cells were not significantly different among patients (Perelson et al., 1996). 
Therefore, if  the amount o f virus in the blood varies between infected animals, detecting
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a correlation between plasma viral loads and certain factors in a wild population would be 
difficult.
FIVpco plasma viral loads were also evaluated in comparison to PBMC proviral 
loads from 11 infected cougars to determine whether a correlation existed between these 
two viral compartments though no correlation was observed. In fact the animal with the 
highest plasma viral load (2.81x10^) maintained a proviral load that was below the lower 
limit o f  detection (Fig. 7). These data suggest that FIVpco may not be produced from 
circulating PBMC. This is consistent with HIV-1 infections where the primary site o f 
virus production is lymphoid tissue (Haase, 1999) and greater than 90% o f H IV -1 plasma 
viremia is maintained by a fraction o f the CD4^ T cell population (Ho, 1997, Hufert et al.,
1997).
The large sequence divergence and widespread distribution o f FIVpco in North 
America indicate that FIVpco has co-evolved with its cougar host for a long time 
(Carpenter et al., 1996). The high cell-associated and cell free viral loads documented in 
infected cougars may be an effective mechanism by which FIVpco can sustain a high 
prevalence rate (30-58%) in a solitary species (Carpenter et al., 1996). Indeed, both FIV 
cell-associated and cell free virus are able to cause infection in domestic cats (Burkhard 
& Dean, 2003, Burkhard et al., 1997). Furthermore, previous FIVpco studies established 
that negative selection, which constrains genetic diversity, dominates in FIVpco infections 
(Biek et al., 2003). Thus the low intrahost viral diversity reported appears to be the result 
o f  an absence o f strong positive selection on the virus and not to low levels o f viral 
replication.
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Our results indicate that a large proportion o f the variability in PBMC proviral 
loads can be ascribed to viral lineage and cougar age (R^ = 0.549). Although the number 
o f PBMC samples quantified was moderate (n = 30), there was a strong correlation 
between PBMC proviral loads to viral lineage and cougar age {P = 0.014). Because 
differences in proviral loads eimong viral lineages were most pronounced in adult cougars 
(Fig. 6), changes in hormone levels associated with sexual maturation or activity may 
influence viral replication. Activation of viral transcription occurs in type B (mouse 
mammary tumor virus) and type C (murine leukemia virus) retroviruses in response to 
adrenal steroids by binding their respective receptors to hormone response elements 
located within the long terminal repeat (LTR) (Cato et al., 1988, Miksicek et al., 1986). 
Therefore, the physiological state o f a maturing infected cougar may influence viral 
replication and ultimately affect the number o f infected circulating cells. Such a 
replication strategy could optimize viral transmission during contact events. Interestingly, 
animals infected with viruses from lineage one and two, which displayed an increase in 
proviral load with age, are from the population with the highest prevalence o f FIVpco 
infection (Biek et al., 2003), suggesting that this strategy leads to a higher likelihood of 
transmission.
In summary, quantification o f FIVpco proviral and plasma viral loads has 
established that infected cougars maintain substantial viral loads that are comparable or 
higher than those reported in endemic primate lentivirus infections. These data further 
support the premise that high levels o f lentiviral replication do not necessarily correlate 
with disease. Finally, differences observed in cougar PBMC proviral loads correlated to
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viral lineage and host age suggesting that different life strategies exist within FIVpco 
lineages.
54
Chapter 4:
Conclusions and Future Prospects
The quantification o f FIVpco proviral and plasma viral loads provided necessary 
information about the amount o f  virus maintained in an endemic lentivirus infection in 
cougars. The study also represented the largest viral load study from a naturally infected 
wild population. Interestingly, significant differences observed among cougar PBMC 
proviral loads correlated to viral lineage and cougar age. Because differences in proviral 
loads among viral lineages were most pronounced in adult cougars, we hypothesize that 
sexual maturation may influence viral replication (see Chapter 3, Discussion). In animals 
sexual maturation is associated with an increase in hormone levels, which may 
differentially influence FIVpco viral replication and result in distinct PBMC proviral loads 
among infecting viral isolates.
Adrenal steroids have been previously shown to both increase and decrease viral 
replication in distinct lentivirus infections. For example, adrenal steroids have been 
previously shown to induce the transcription o f type B (mouse mammary tumor virus, 
MMTV) and type C (murine leukemia virus, MLV) retroviruses (Cato et al., 1988, 
Miksicek et al., 1986). In contrast, glucocorticoid dexamethasone (DXM), a steroid 
hormone that binds the glucocorticoid receptor, blocks the activation o f HIV -1 replication 
in chronically infected cell lines and infected PBMC (Laurence et al., 1989, Mitra et al., 
1993). Steroid hormones exert their effect on viral transcription by binding their 
respective receptors, translocating to the nucleus and binding hormone response elements 
located within the long terminal repeat (LTR) o f the proviral DNA.
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In addition to the significant differences observed among PBMC proviral loads, 
FIVpco lineages differ genetically within their LTR response elements (data not shown). 
Consequently, the possibility exists that separate FIVpco isolates may respond 
differentially to hormone treatment. Therefore, future experiments may entail in vitro 
studies to investigate the effect o f hormones on viral transcription and replication.
For example, cultured cougar cells infected with separate viral isolates could be 
stimulated with a series o f steroid hormones to determine whether infected cells respond 
differentially to hormone treatment. Genetic data from FIVpco LTR sequences have 
revealed that both the glucocorticoid receptor (OR) and the pituitary transcription factor 1 
(Pit-1) response element are differentially encoded with the LTR between FIVpco viral 
lineages. OR is a member o f a family o f  steroid receptors that bind glucocorticoid 
hormones (GCs) such as cortisol and DXM. GCs regulate physiological responses by 
binding to and modulating the transcriptional activity o f the GR (Picard et al., 1990). 
Alternatively, expression levels o f P it-1 have been shown to increase in response to other 
hormones inplicated in sexual maturation such as growth hormone (GH) and prolactin 
(PRL) (Gonzalez-Parra et al., 1998). Therefore, these four steroids, cortisol, DXM, GH 
and PRL may be appropriate hormones to begin an initial investigation of their effects on 
FIVpco viral replication.
The level o f viral replication in infected cougar PBMC can be measured through a 
relative real-time PCR assay, which is able to measure changes in target mRNA levels. 
Relative real-time PCR quantifies mRNA levels o f a target gene, in this case possibly orf- 
and evaluates orf-A expression levels against expression levels o f a gene known to 
remain constant during the cell cycle, for example glyceraldehyde-3-phosphate
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dehydrogenase (GAPDH). Cougar PBMC, infected with different viral isolates could be 
treated with steroid hormones and the level o f  viral replication can be assayed over a 
period o f  time. Additionally FIVpco proviral loads can be quantified during steroid 
treatment to understand whether proviral loads change with different hormone treatments. 
Since proviral loads from both the black and gray lineages increase over time, one can 
hypothesize that PBMC infected with these two viral lineages may increase viral 
replication and possibly increase proviral loads over the course o f hormone treatment. If 
this is indeed the case then a separate study could investigate the physical interactions o f 
binding the hormone receptor to the LTR o f FIVpco.
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